Our mission is to identify novel drug targets and effective therapeutics for fibrosis and solid tumours by testing cells in their natural microenvironment using our pioneering human extracellular matrix platform. We are developing a portfolio of programmes in fibrosis and solid tumours using our proprietary human extracellular matrix (ECM)-based discovery platform. The use of physiologically realistic human in vitro models is ...
Our mission is to identify novel drug targets and effective therapeutics for fibrosis and solid tumours by testing cells in their natural microenvironment using our pioneering human extracellular matrix platform. We are developing a portfolio of programmes in fibrosis and solid tumours using our proprietary human extracellular matrix (ECM)-based discovery platform. The use of physiologically realistic human in vitro models is transforming our ability to identify new targets, determine mechanisms of action, and increase the success rate of therapeutic candidates.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.